UK Markets closed

Orthofix Medical Inc. (OFIX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
40.66+0.16 (+0.40%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5795.26M
Enterprise value 3717.41M
Trailing P/E N/A
Forward P/E 133.60
PEG ratio (5-yr expected) 15.92
Price/sales (ttm)1.95
Price/book (mrq)2.23
Enterprise value/revenue 31.76
Enterprise value/EBITDA 731.41

Trading information

Stock price history

Beta (5Y monthly) 1.15
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 348.50
52-week low 328.32
50-day moving average 340.61
200-day moving average 341.76

Share statistics

Avg vol (3-month) 391.99k
Avg vol (10-day) 3105.97k
Shares outstanding 519.56M
Implied shares outstanding 6N/A
Float 19.06M
% held by insiders 12.71%
% held by institutions 1101.33%
Shares short (27 May 2021) 4293.35k
Short ratio (27 May 2021) 43.31
Short % of float (27 May 2021) 42.47%
Short % of shares outstanding (27 May 2021) 41.50%
Shares short (prior month 29 Apr 2021) 4314.77k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Mar 2021

Profitability

Profit margin -7.11%
Operating margin (ttm)-3.05%

Management effectiveness

Return on assets (ttm)-1.54%
Return on equity (ttm)-8.16%

Income statement

Revenue (ttm)407.33M
Revenue per share (ttm)21.04
Quarterly revenue growth (yoy)0.70%
Gross profit (ttm)304.67M
EBITDA 22.84M
Net income avi to common (ttm)-28.96M
Diluted EPS (ttm)-1.50
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)94.57M
Total cash per share (mrq)4.84
Total debt (mrq)27.48M
Total debt/equity (mrq)7.74
Current ratio (mrq)2.66
Book value per share (mrq)18.22

Cash flow statement

Operating cash flow (ttm)64.25M
Levered free cash flow (ttm)63.33M